A bill to amend title XIX of the Social Security Act to stop cost shifting by pharmaceutical companies to health care providers by repealing the use of best price and increasing the discount used in determining rebates for prescription drugs purchased under medicaid, to ensure the restoration of prescription drug discounts to various Federal programs, and for other purposes.